Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parakkal Deepak

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2020
Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel DiseaseMallory E Cohen, Parakkal Deepak, Geetika Khanna, et al.
Drug Safety|April 13, 2013
Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting SystemAllison Salk, Derrick J Stobaugh, Parakkal Deepak, et al.
The Annals of Pharmacotherapy|March 29, 2013
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literatureAllison Salk, Derrick J Stobaugh, Parakkal Deepak, et al.
World Journal of Gastroenterology|January 25, 2013
Lubiprostone induced ischemic colitisMuhammed Sherid, Humberto Sifuentes, Salih Samo, et al.
Inflammatory Bowel Diseases|February 13, 2019
Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and InfliximabMartin H Gregory, Matthew A Ciorba, Parakkal Deepak, et al.
The American Journal of Gastroenterology|April 30, 2019
Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy ProgramMichael S Epstein, Eric D Shah, Parakkal Deepak, et al.
Inflammatory Bowel Diseases|August 11, 2016
Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and TrialsParakkal Deepak, Joel G Fletcher, Jeff L Fidler, et al.
Inflammatory Bowel Diseases|July 17, 2018
Novel Imaging Approaches in Inflammatory Bowel DiseasesParakkal Deepak, Kathryn J Fowler, Joel G Fletcher, et al.
Digestive Diseases and Sciences|October 25, 2017
Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's DiseaseChung Sang Tse, Parakkal Deepak, Thomas C Smyrk, et al.
Clinical Nuclear Medicine|March 27, 2024
Inflammatory and Malignant Uptake Along Crohn Perianal Fistula on 18 F-FDGSpencer McKinley, Favour Garuba, Malak Itani, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2020
Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel DiseaseMallory E Cohen, Parakkal Deepak, Geetika Khanna, et al.
Drug Safety|April 13, 2013
Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting SystemAllison Salk, Derrick J Stobaugh, Parakkal Deepak, et al.
The Annals of Pharmacotherapy|March 29, 2013
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literatureAllison Salk, Derrick J Stobaugh, Parakkal Deepak, et al.
World Journal of Gastroenterology|January 25, 2013
Lubiprostone induced ischemic colitisMuhammed Sherid, Humberto Sifuentes, Salih Samo, et al.
Inflammatory Bowel Diseases|February 13, 2019
Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and InfliximabMartin H Gregory, Matthew A Ciorba, Parakkal Deepak, et al.
The American Journal of Gastroenterology|April 30, 2019
Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy ProgramMichael S Epstein, Eric D Shah, Parakkal Deepak, et al.
Inflammatory Bowel Diseases|August 11, 2016
Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and TrialsParakkal Deepak, Joel G Fletcher, Jeff L Fidler, et al.
Inflammatory Bowel Diseases|July 17, 2018
Novel Imaging Approaches in Inflammatory Bowel DiseasesParakkal Deepak, Kathryn J Fowler, Joel G Fletcher, et al.
Digestive Diseases and Sciences|October 25, 2017
Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's DiseaseChung Sang Tse, Parakkal Deepak, Thomas C Smyrk, et al.
Clinical Nuclear Medicine|March 27, 2024
Inflammatory and Malignant Uptake Along Crohn Perianal Fistula on 18 F-FDGSpencer McKinley, Favour Garuba, Malak Itani, et al.
Pageof 18